Phase Forward

Phase Forward is the leading provider of data management solutions for clinical trials and drug safety, offering proven solutions in electronic data capture (EDC), clinical data management (CDM), and adverse event reporting (AER) as either an integrated solution or as stand-alone applications. We are the only company that can offer you the market leading products in data capture, data management, and safety as an integrated solution

Contact Details: 880 Winter Street Waltham Massachusetts 02451 United States of America Tel: 1.888.703.1122 Fax: Email: webmaster@phaseforward.com WWW: www.domainpharma.com/

Loading...

Recent Publications by Phase Forward:
Signal detection methodologies to support effective safety management. The increased focus on the safety of medical products, as well as the...	11th September, 2007	Phase Forward Lincoln Technologies, Waltham, MA 02451, USA.	Expert Opin Drug Saf. 2007 Jul;6(4):451-64. DOI Direct Link

Press Releases on Phase Forward:
Reportlinker Adds Data Mining in Drug Development and Translational Medicine	26th October, 2009	Reportlinker	-- Business models and solutions in drug development bioinformatics The mountain of data generated and stored is growing ever-higher. The information content of life science data is
MedAptus Expands Board of Directors	16th April, 2009	MedAptus	BOSTON, April 16 /PRNewswire/ -- MedAptus(R), market leader for charge capture technologies, today announced the addition of two new, independent directors, Linda Beneze and Laurence J. Hagerty, to
Frost & Sullivan Recognizes Excellence in Medical Technologies & Life Sciences	24th March, 2009	Frost & Sullivan	MOUNTAIN VIEW, Calif., March 24 /PRNewswire/ -- Frost & Sullivan, the Growth Partnership Company, honored recipients of its 2009 Excellence in Medical Technologies & Life Sciences Awards at a
Schroder Ventures Life Sciences fund raises over US $400 million for	1st May, 2003	Schroder	Schroder Ventures Life Sciences fund raises over US $400 million for Third International Life Sciences Fund  London and Boston

BioNews Results for Phase Forward:
POZEN Announces Start of Enrollment For PA32540 Phase 3 Program	Pharma Live:  Nov 23 2009 2:59AM Matching: phase forward
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients	PR Newswire:  Nov 23 2009 12:46AM Matching: phase forward
POZEN Announces Start of Enrollment For PA32540 Phase 3 Program	Pharmacy Choice:  Nov 20 2009 11:07PM Matching: phase forward
POZEN Announces Start of Enrollment For PA32540 Phase 3 Program	SmartBrief:  Nov 20 2009 3:36PM Matching: phase forward
POZEN Announces Start of Enrollment For PA32540 Phase 3 Program	Genetic Engineering News:  Nov 20 2009 2:28PM Matching: phase forward
Promote your company here: BioNewsCast - Press Release Distribution	→View more Phase Forward news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 185 times since April 2007, the link to the organisation's website has been followed 29 times

Search for more companies in Waltham

Search for more companies in Massachusetts

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Phase Forward